City Therapeutics (NASDAQ:CTY) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of City Therapeutics (NASDAQ:CTY) to a hold rating in a research report released on Saturday,Wall Street Zen reports.

City Therapeutics Price Performance

Shares of NASDAQ:CTY opened at $20.79 on Friday. City Therapeutics has a fifty-two week low of $19.75 and a fifty-two week high of $23.88.

Insider Activity

In other news, major shareholder Arch Venture Partners Xii, Llc bought 170,000 shares of the business’s stock in a transaction that occurred on Monday, October 19th. The stock was acquired at an average cost of $18.00 per share, for a total transaction of $3,060,000.00. Following the completion of the purchase, the insider owned 13,692,507 shares of the company’s stock, valued at $246,465,126. This trade represents a 1.26% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Robert Nelsen acquired 170,000 shares of City Therapeutics stock in a transaction dated Monday, October 19th. The shares were acquired at an average cost of $18.00 per share, with a total value of $3,060,000.00. Following the completion of the acquisition, the director directly owned 13,692,507 shares in the company, valued at $246,465,126. This trade represents a 1.26% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure.

About City Therapeutics